Open AccessContinued use of azithromycin for mild COVID-19 in India: Evidence and implications?
Author(s) -
Saurav Misra,
Shubham Atal,
Balakrishnan Sadasivam
Publication year - 2021
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_812_21
Subject(s) - medicine , azithromycin , tolerability , observational study , dosing , intensive care medicine , pandemic , clinical trial , adverse effect , drug , covid-19 , randomized controlled trial , antibiotics , pharmacology , infectious disease (medical specialty) , disease , microbiology and biotechnology , biology